Opus Genetics, Inc. (NASDAQ:IRD), a pharmaceutical preparations company with a market capitalization of $36.3 million, has updated its executive employment agreements, enhancing severance terms for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback